Valenzuela; Pablo D. T.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Valenzuela; Pablo D. T..The latest application filed is for "multiple epitope fusion protein".
- Valenzuela; Pablo D. T. - Berkeley CA
- Valenzuela; Pablo D. T. - Santiago CL
- Valenzuela; Pablo D. T. - San Francisco CA
| Patent | Date |
|---|---|
| Multiple epitope fusion protein Grant 7,056,658 - Valenzuela , et al. June 6, 2 | 2006-06-06 |
| Compositions comprising polynucleotides encoding human fibroblast growth factor receptor and uses thereof Grant 6,844,168 - Keifer , et al. January 18, 2 | 2005-01-18 |
| Hybrid DNA synthesis of mature insulin-like growth factors Grant 6,642,029 - Valenzuela , et al. November 4, 2 | 2003-11-04 |
| Multiple epitope fusion protein App 20030044774 - Valenzuela, Pablo D.T. ; et al. | 2003-03-06 |
| Expression and use of human fibroblast growth factor receptor Grant 6,255,454 - Keifer , et al. | 2001-07-03 |
| Hybrid particle immunogens Grant 5,792,463 - Valenzuela , et al. August 11, 1 | 1998-08-11 |
| Expression of recombinant glycoprotein B from herpes simplex virus Grant 5,759,814 - Burke , et al. June 2, 1 | 1998-06-02 |
| Recombinant herpes simplex gB-gD vaccine Grant 5,750,114 - Burke , et al. May 12, 1 | 1998-05-12 |
| Recombinant herpes simplex gB-gD vaccine Grant 5,747,039 - Burke , et al. May 5, 1 | 1998-05-05 |
| Formulation and procedure to increase resistance of plants to pathogenic agents and environmental stress Grant 5,733,851 - Villanueva , et al. March 31, 1 | 1998-03-31 |
| Herpes simplex virus glycoprotein B vaccine Grant 5,648,079 - Burke , et al. July 15, 1 | 1997-07-15 |
| Recombinant herpes simplex gD vaccine Grant 5,612,041 - Burke , et al. March 18, 1 | 1997-03-18 |
| Expression of recombinant glyoprotein B from herpes simplex virus Grant 5,244,792 - Burke , et al. September 14, 1 | 1993-09-14 |
| Expression and use of human fibroblast growth factor receptor Grant 5,229,501 - Keifer , et al. | 1993-07-20 |
| Recombinant herpes simplex gb-gd vaccine Grant 5,171,568 - Burke , et al. December 15, 1 | 1992-12-15 |
| Hepatitis surface antigen particle vaccine Grant 5,098,704 - Valenzuela March 24, 1 | 1992-03-24 |
| Hybrid DNA synthesis of insulin Grant 5,015,575 - Brake , et al. * May 14, 1 | 1991-05-14 |
| Promotion of corneal stroma wound healing with human epidermal growth factor prepared from recombinant DNA Grant 4,959,353 - Brown , et al. September 25, 1 | 1990-09-25 |
| Alpha factor leader sequence directed secretion of insulin Grant 4,914,026 - Brake , et al. April 3, 1 | 1990-04-03 |
| Eukaryotic regulatable transcription Grant 4,880,734 - Burke , et al. * November 14, 1 | 1989-11-14 |
| Eukaryotic regulatable transcription Grant 4,876,197 - Burke , et al. October 24, 1 | 1989-10-24 |
| Amplified expression vector Grant 4,820,642 - Edman , et al. April 11, 1 | 1989-04-11 |
| Hybrid particle immunogens Grant 4,722,840 - Valenzuela , et al. February 2, 1 | 1988-02-02 |
| Expression of glycoprotein D of herpes simplex virus Grant 4,618,578 - Burke , et al. October 21, 1 | 1986-10-21 |
| Adenovirus promoter system Grant 4,510,245 - Cousens , et al. April 9, 1 | 1985-04-09 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 